Gilead to acquire Tubulis to expand ADC oncology capabilities

Sanofi reports positive phase 2 results for lunsekimig in asthma and CRSwNP

Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data

Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease

Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal

ALK secures EU approval for EURneffy 1 mg as needle-free adrenaline option for children

4DMedical secures EU approval for CT:VQ as EUR83m funding fuels European expansion

Almirall reports lebrikizumab demonstrated sustained long-term control in atopic dermatitis through four years

AstraZeneca's tozorakimab meets primary endpoints in two Phase III COPD trials

Eisai and Nuvation Bio report taletrectinib MAA validated by European regulator

Akeso's Phase II trials of AK146D1 and AK138D1 approved in China

UCB selects PANTHERx Rare to distribute KYGEVVI for TK2d

Roche launches new test to help clinicians treat patients with respiratory infections

GSK secures Japan Orphan Drug status for lung cancer ADC

Dizal meets primary endpoint in Phase 3 study of ZEGFROVY (sunvozertinib) monotherapy